By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Peter Attia MD202 - Peter on nutrition, disease prevention, and more — looking back on the last 100 episodes
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
At a glance
WHAT IT’S REALLY ABOUT
Peter Attia revisits changed views on health, longevity, and Formula 1
- Attia frames the episode around 'strong convictions, loosely held,' arguing that updating beliefs with new evidence is a strength and explaining why that makes him lukewarm about publishing a book.
- On disease, he has become more aggressive about immunotherapy's promise, early and frequent GI cancer screening, lowering apoB early and deeply, and genes that modify APOE4 risk in Alzheimer's.
- On nutrition and exercise, he now believes most time-restricted feeding benefit comes from eating less, that protein is under-consumed, and that cardiorespiratory fitness and strength carry an outsized effect on lifespan and healthspan.
- He is unimpressed by NAD precursors, cautions that psychedelics work best paired with psychotherapy, plays down blue light, and now favors trazodone for sleep after Phenibut became hard to get.
- The episode ends with a Formula 1 primer covering the five determinants of winning, the 2022 rule changes, qualifying, tire strategy, and season predictions.
IDEAS WORTH REMEMBERING
5 ideasChanging your mind is a feature, not a flaw
Attia borrows the phrase from a hedge fund friend and argues that science and medicine, like investing, require updating positions as new information arrives, though people tend to dig in.
Designer immunotherapies may treat most metastatic solid cancers
Attia notes that 80% of patients have neoantigens recognized by the immune system, which makes him predict that in about 10 years engineered cell therapies could be out of trials, though insurance coverage may lag.
Screen for colon cancer much earlier and more often
He argues nobody should die of colon cancer because polyps are visible and removable. His practice starts colonoscopy at 40 and he suspects every one to three years is better than the current five to ten.
Lower apoB early and deeply
Citing infantile levels of 30 to 40 mg/dL and Mendelian randomization data, he now favors treating early and keeping apoB below roughly 60, with ceiling at about the fifth percentile.
Time-restricted feeding mostly works through fewer calories
He sees no magic in the fasting window itself, and warns that aggressive restriction with low protein can cost lean mass while adding fat, as seen on DEXA scans.
WORDS WORTH SAVING
5 quotesNobody should ever die from colon cancer, and I would add the same for esophageal and stomach.
— Peter Attia
I really think that in 10 years we're going to basically be using designer-based immunotherapies to eradicate most solid organ metastatic cancers. That's a bold-ass statement.
— Peter Attia
The good news is this tool called exercise, which is broad, includes a lot of things, it's not just one thing, so by definition it needs to be multimodal, it has an unbelievable impact on your lifespan and healthspan, probably bigger than anything else, and it's available to everyone.
— Peter Attia
I think the RDA is predicated on how much protein you need to, like, live versus how much protein you need to thrive.
— Peter Attia
Two years ago I was kind of like meh, and now I'm three levels below meh.
— Peter Attia
High quality AI-generated summary created from speaker-labeled transcript.